학술논문
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
10837159